Natali Minassian

Natali Minassian has extensive experience in drug discovery and pharmacology, currently serving as Associate Scientific Director at Neurocrine Biosciences since November 2017, where responsibilities include leading biology initiatives on drug discovery project teams and developing robust assays for the drug discovery process. Prior roles include Senior Scientist at Ardelyx, Inc. focusing on cellular and molecular pharmacology, and Senior Scientist for the Neuroscience Pain & Research Unit at Pfizer, where expertise in electrophysiology was utilized for CNS disorders. Minassian's career began with a PhD in Molecular, Cellular, and Integrative Physiology from UCLA and has included postdoctoral fellowships focused on ion channels and neuroscience. Educational credentials include a BS in Biology from Santa Clara University and an AA in Independent Studies from Foothill College.